A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome

References

• Akacha, M., F. Bretz, and S. Ruberg. 2017. Estimands in clinical trials - broadening the perspective. Statistics in Medicine 36 (1):5–19. doi:10.1002/sim.v36.1.
   PubMed Web of Science ®Google Scholar
• Angrist, J. D., G. W. Imbens, and D. B. Rubin. 1996. Identification of causal effects using instrumental variables. Journal of the American Statistical Association 91:444–455. doi:10.1080/01621459.1996.10476902.
   Web of Science ®Google Scholar
• Carpenter, J. R., J. H. Roger, S. Cro, and M. G. Kenward. 2014. Response to comments by Seaman et al. on “analysis of longitudinal trials with protocol deviation: A framework for relevant, accessible assumptions, and inference via multiple imputation. Journal of Biopharmaceutical Statistics 24 (6):1363–1369. doi:10.1080/10543406.2014.960085.
   PubMed Web of Science ®Google Scholar
• Carpenter, J. R., J. H. Roger, and M. G. Kenward. 2013. Analysis of longitudinal trials with protocol deviation: A framework for relevant, accessible assumptions, and inference via multiple imputation. Journal of Biopharmaceutical Statistics 23 (3):1352–1371. doi:10.1080/10543406.2013.834911.
   PubMedGoogle Scholar
• Cro, S., J. R. Carpenter, and M. G. Kenward. 2019. Information-anchored sensitivity analysis: Theory and application. Journal of the Royal Statistical Society: Series A (Statistics in society) 182 (2):623–645. doi:10.1111/rssa.2019.182.issue-2.
   PubMed Web of Science ®Google Scholar
• Dunn, G., M. Maracy, C. Dowrick, J. L. Ayuso-Mateos, O. S. Dalgard, H. Page, V. Lehtinen, P. Casey, C. Wilkinson, J. L. Vazquez-Barquero, et al. 2003. Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-up. British Journal of Psychiatry 183 (4):323–331. doi:10.1192/bjp.183.4.323.
   PubMedGoogle Scholar
• European Medicines Agency. 2017. ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials. Accessed April 24, 2018. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2017/08/WC500233916.pdf.
   Google Scholar
• Kenward, M., E. Goetghebeur, and G. Molenberghs. 2001. Sensitivity analysis for incomplete categorical data. Statistical Modelling 1 (1):31–48. doi:10.1177/1471082X0100100104.
   Web of Science ®Google Scholar
• Little, R., and S. Kang. 2015. Intention-to-treat analysis with treatment discontinuation and missing data in clinical trials. Statistics in Medicine 34 (16):2381–2390. doi:10.1002/sim.v34.16.
   PubMed Web of Science ®Google Scholar
• Little, R., and L. Yau. 1996. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics 52 (4):1324–1333. doi:10.2307/2532847.
   PubMed Web of Science ®Google Scholar
• Little, R. J., and D. B. Rubin. 2000. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. Annual Review of Public Health 21 (1):121–145. doi:10.1146/annurev.publhealth.21.1.121.
   PubMed Web of Science ®Google Scholar
• Liu, G. F., and L. Pang. 2016. On analysis of longitudinal clinical trials with missing data using reference-based imputation. Journal of Biopharmaceutical Statistics 26 (5):924–936. doi:10.1080/10543406.2015.1094810.
   PubMed Web of Science ®Google Scholar
• Liublinska, V., and D. B. Rubin. 2014. Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trial. Statistics in Medicine 33 (24):4170–4185. doi:10.1002/sim.6197.
   PubMed Web of Science ®Google Scholar
• Mallinckrodt, C. H., Q. Lin, I. Lipkovich, and G. Molenberghs. 2012. A structured approach to choosing estimands and estimators in longitudinal clinical trials. Pharmaceutical Statistics 11 (6):456–461. doi:10.1002/pst.v11.6.
   PubMed Web of Science ®Google Scholar
• National Research Council. 2010. The prevention and treatment of missing data in clinical trials. Washington, DC: Panel on Handling Missing Data in Clinical Trials. Committee on National Statistics, Division of Behavioral and Social Sciences and Education. The National Academies Press.
   Google Scholar
• Oehlert, G. W. 1992. A note on the delta method. The American Statistician 46 (1):27–29.
   Web of Science ®Google Scholar
• Permutt, T. 2016. A taxonomy of estimands for regulatory clinical trials with discontinuations. Statistics in Medicine 35 (17):2865–2875. doi:10.1002/sim.v35.17.
   PubMed Web of Science ®Google Scholar
• Ratitch, B., M. O’Kelly, and R. Tosiello. 2013. Missing data in clinical trials: From clinical assumptions to statistical analysis using pattern mixture models. Pharmaceutical Statistics 12:337–347. doi:10.1002/pst.v12.6.
   PubMed Web of Science ®Google Scholar
• Rubin, D. B. 1987. Multiple imputation for nonresponse in surveys. New York: John Wiley and Sons.
   Google Scholar
• Seaman, S., F. Leacy, and I. R. White. 2014. Re: Analysis of longitudinal trials with protocol deviations — a framework for relevant, accessible assumptions, and inference via multiple imputation (carpenter, Roger and Kenward, journal of biopharmaceutical statistics 2013;23:1352–1371). Journal of Biopharmaceutical Statistics 24:1358–1362. doi:10.1080/10543406.2014.928306.
   PubMed Web of Science ®Google Scholar
• Yan, X., S. Lee, and N. Li. 2009. Missing data handling methods in medical device clinical trials. Journal of Biopharmaceutical Statistics 19 (6):1085–1098. doi:10.1080/10543400903243009.
   PubMed Web of Science ®Google Scholar